Clinical Trial: Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia
Study Status: Completed
Recruit Status: RECRUITING
Condition: Acute Myeloid Leukemia, Adult
Study Type: INTERVENTIONAL
Official Title: A Monocenter Prospective Single Arm Study of Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for Induced Therapy in Adults de Novo Acute Myeloid Leukemia (Non-M3)
Brief Summary:
The goal of this clinical trial is to evaluate the response and safety of Cladribine plus Homoharringtonine and Cytarabine regimen (CHA) protocol in de novo acute myeloid leukemia with age <60y.This is a prospective, single-armed mono-center based investigator-initiated trial.About 30 patients who meet the enrollment criteria with be treated with CHA as induction chemotherapy.The complete response rate, survival rate, recurrence rate, and treatment-related mortality with be observed.
Read more